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Abstract: Interaction of 784 intergenic, 686 intronic and 49 exonic miRNAs with mRNAs of 
51 genes coding in-miRNAs were investigated. 43 genes are targets for ig-miRNAs, 44 for in-
miRNAs and 17 for ex-miRNAs. These genes are affected by 92 ig-miRNAs, 128 in-miRNAs and 
15 ex-miRNAs. Density of miRNA sites is higher in 5'UTR than it is in CDS and 3'UTR. Three 
types of miRNA interaction with mRNA were revealed. 5'-dominant canonical, 3'-compensatory 
and complementary types binding sites were revealed. Intronic miRNAs (in-miRNA) do not interact 
with mRNAs of host genes. Linkage between different mRNAs of genes encode in-miRNAs via 
other in-miRNAs are revealed. These data promote understanding of interaction mechanism of 
miRNA with mRNA genes participating in gastrointestinal cancer and development of 
microRNomics. 
Keywords: ig-miRNA; in-miRNA; ex-miRNA; mRNA; 5'UTR; CDS; 3'UTR; human, 
oncogene 
 
Introduction 
MicroRNAs (miRNA) are non-protein coding nucleotide sequences that have length about 22 
nucleotides. They are evolutionary conservative in many organisms and accomplish important 
regulatory function (Ibanez-Ventoso et al., 2008). The binding miRNA to mRNA leads to specific 
splitting, deadenylation or translation repression (Pillai et al., 2007). Their number is considerably 
enlarged due to new methods of search and comparison of targets.  
MiRNAs regulate translation of about 60% of all human non-protein-coding genes (Friedman 
et al., 2009). A mRNA can have some binding sites with one or with several miRNAs. Hence, the 
influence of miRNA on inhibition of mRNA translation becomes greater (Baek et al., 2008; Selbach 
et al., 2008; Grimson et al., 2007). Deregulation in miRNA expression is one main cause of cancer 
(Hamano et al., 2011), cardiovascular (Small et al., 2010) and other diseases (Jiang et al., 2010). 
Aberrant some miRNA expression have been well characterized in different oncology diseases, with 
implications for progression and prognosis (Cortez et al., 2012). Expression of some miRNAs 
changes in development esophageal cancer (Fang et al., 2012), gastric cancer (Lu et al., 2011), 
colorectal cancer (Hamfjord et al., 2012), breast cancer (Hafez et al., 2012; Hanna et al., 2012) and 
other types. 
Recently, many programs for miRNA sites prediction have been developed (Sethupathy et al., 
2006). A search for sites in the presence of complementary seed (part of 5'-end miRNA site) is 
carried out. The seed length depends on the program and ranges between 6 and 8 nt. (Friedman et 
al., 2009; Lewis et al., 2003). Site searching for only short seed leads to the prediction of 
considerable quantity of false sites. Some programs take advantage of seed conservation to assess 
site specificity. However there are many nonconservative seed-site of miRNAs already known 
(Baek et al., 2008). Some programs predict not perfectly complementary seed in the presence of 3'-
compensatory site (Farh et al., 2005).  
Most programs allow to search for sites only in 3'UTR (Maragkakis et al., 2011). Recently, it 
was shown that miRNA sites may also occur in ORF (Baek et al., 2008). Many researchers consider 
that miRNAs interact with mRNAs only in 3'UTR (Delay et al., 2011; Iorio et al., 2009; Isik et al., 
2010;  Kruger et al., 2006; Satoh et al., 2011), however publications which describe miRNA binding 
to mRNA in 5'UTR and CDS are known (Duursma et al., 2008; Elcheva et al., 2009; Kulkarni et al., 
2011; Moretti et al., 2010; Tsai et al., 2009).  
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 The functionality of predicted sites according seed is checked experimentally, however other 
sites are not predicted by such method (Qin et al., 2010; Shirdel et al., 2011). In all cases, a miRNA 
site definition relies on the presence of some seed. Although some energy is calculated for a site, it 
is less important than the seed for the selection of a target mRNA. Program RNAhybrid relies on 
thermodynamics and allows to search for target sites subject to 5'-dominant initial, 5'-seed-dominant 
and 3'-compensatory types (Garcna et al., 2011). An accurate identification of miRNA:mRNA pairs 
should promote considerable development of diagnostic methods of various cancer diseases. 
The present research aims to reveal binding miRNA sites with various parts of mRNA 
(5'UTR, CDS and 3'UTR) and define nucleotide interaction features of miRNA:mRNA complexes. 
This study is realized for mRNAs involved in cancer and should extend to other gene families.  
 
Materials and Methods 
Nucleotide sequences of miRNAs and their precursors were found from miRBase 
(http://www.mirbase.org). mRNA sequences of all genes (Homo sapiens, Genome build 37.2.) were 
searched in obtained from GenBank (http://www.ncbi.nlm.nih.gov). Then, miRNAFinder 2.2 
(http://sites.google.com/site/malaheenee/software/) was used to find miRNA origins (intergenic, 
exonic or intronic). A literature review of genes coding intronic miRNAs led to 51 genes (Table S. 
1) that encode proteins participating in gastrointestinal and breast cancer. These information was 
collected according to articles from US National Library of Medicine National Institutes of Health 
PubMed (http://www.ncbi.nlm.nih.gov/pubmed) (S. references). 
Software RNAHybrid 2.1. was run for all pairs (miRNA:mRNA) and provided postions of 
potential binding sites miRNAs in mRNAs, their energies ΔG and scheme of their interaction. Our 
script E-RNAhybrid (http://sites.google.com/site/malaheenee/software/) computes the ratio 
ΔG/ΔGm, p-value, equalizing coefficient and type corresponding regions (5'UTR, CDS or 3'UTR), 
where miRNA site disposes. To achieve this, a quantitative criterion is defined. A ratio ΔG/ΔGm 
value (%), where ΔGm equals binding energy for miRNA with perfectly complementary nucleotide 
sequence, is computed. Number of binding sites in 5'UTR, CDS and 3'UTR was computed as the 
number of sites divided to nucleotide length of this region and multiplied by 10
3
 (s/l), that is 
calculation per 1000 nucleotides. Reliability degree (p-value) is estimated, that relies on ΔG and its 
standard deviation. Threshold significance is set to p<0.0005.  
Energy of miRNA binding site with mRNA depends on number of complementary nucleotide  
pairs. The miRNA length is an important parameter in selection of binding sites. The miRNA length 
varies in range 16-27 n. If the length miRNA is shorter, the probability of receiving false positive 
results is higher, so the equalizing coefficient was entered. It was revealed according to distribution 
of miRNA length that the majority miRNAs have 21 n., which was it is taken as basic value. Values 
of equalizing coefficient was calculated in the searching of all studied miRNA sites on casual 
nucleotide sequences, that have average length of mRNAs. If the miRNA length is more than 21 n., 
value of threshold significance (p) divided into equalizing coefficient, thus reliability becomes 
higher. In case, the miRNA length is less than 21 n., value of threshold significance (p) multiplied 
by the corresponding coefficient, thus reliability becomes less. 
 
Results  
784 intergenic, 686 intronic and 49 exonic miRNAs were found by program miRNAFinder 
2.2. 471 genes encode 686 intronic pre-miRNAs. Each gene encode one or more in-miRNAs. 
Among them only 51 encode proteins participating in development of gastrointestinal and breast 
cancer according to literature review of all these genes. Characteristics 51 genes are represented in 
Table S. 1. Five genes (ATF2, BID, DMD, EVL, FOXP1) encode intronic pre-miRNAs in their 
3'UTRs and another five genes (BBC3, EPHB2, NR2F2, PTPRJ, SPATA13) encode intronic pre-
miRNAs in their 5'UTRs. Some genes encode one or more in-miRNA. For example, AATK gene 
encodes pre-miR-338, pre-miR-657 and pre-miR-1250; HDAC4 gene encodes  pre-miR-2467, pre-
miR-4440 and pre-miR-4441. 
 Interaction of all intergenic, intronic and exonic miRNAs with mRNAs of 51 genes were 
investigated by programs RNAHybrid 2.1 and E-RNAhybrid. We show a linkage between different 
mRNA of genes encode in-miRNAs via other in-miRNAs (Table S. 3). Binding sites to miRNAs 
according to threshold significance (p < 0.0005) with equalizing coefficient (Table S. 4 – 8). Similar 
results can be found on three types of miRNA. We show that binding may involve any mRNA 
region (5'UTR, CDS and 3'UTR). The density of sites and their distribution on these mRNA regions 
were revealed. We consider an example, HDAC4 mRNA that has several types of binding sites 
completely. Complementary type of miRNA binding sites was found after analyze of our results, by 
this mean we improve a classification of miRNA binding sites according to their localization. 
 
 Interaction of intergenic miRNA with mRNA genes coding in-miRNA 
 Binding sites of 784 ig-miRNAs with these mRNAs were studied. 43 mRNAs were found to 
be targets for ig-miRNAs and 8 mRNAs (ABCF1, BIRC6, DCC, EBF3, FBXW7, IGF2, SLIT2, 
TNFAIP6) have no binding sites to ig-miRNAs (p < 0.0005). Only 92 out of 784 ig-miRNAs are 
involved (Table S. 4, 5). The number and density of binding sites of ig-miRNAs to mRNAs depend 
on the mRNAs.  
Shares of binding sites for ig-miRNAs are 15.8%, 57.7% and 26.5% in 5'UTR, CDS, 3'UTR 
of 49 mRNAs, respectively (Figure 1, A). However, the average number of binding sites in 5'UTR, 
CDS and 3'UTR mRNA is 2.54 s/l, 0.99 s/l and 0.90 s/l, respectively for these genes (Figure 1, B). 
Table S. 4 represents the data for the 35 genes with a small number (one to six) of ig-miRNA sites. 
These ig-miRNAs have only one site in mRNA-targets. Data for 8 remaining genes, that have seven 
or more binding sites to ig-miRNAs are given in Table S. 5. Some mRNAs have more than one 
interaction site with one ig-miRNA. For example, miR-4472 has four sites in LRP1 mRNA and two 
sites in NOTCH1 and AATK mRNAs. The site number ranges from 0.19 s/l (ABCA6 mRNA) to 5.47 
s/l (BBC3 mRNA) with an average value of 0.94 s/l. (Table S. 9) The highest numbers are found for 
AATK, BBC3, HDAC4, HUWE1, IGF1R, LRP1, NOTCH1 and SLIT3 mRNAs, with 13, 10, 13, 7, 8, 
12, 8 and 10 binding sites, respectively. 
 Ig-miRNA sites with the best characteristics are represented in Tables 1 – 3, there are results 
with the ratio ΔG/ΔGm 80% and more (with equalizing coefficient). Table 1 shows characteristics of 
some  ig-miRNA sites in 5'UTR. The ratio ΔG/ΔGm of these miRNA sites changes in diapason 80-
92%. Translation some mRNAs can be regaled by different miRNA. For example, NR2F2 gene 
have four binding sites; EPCAM, HNF4A and SLIT3 genes have three sites and EGFL7, HDAC4, 
LRP1 genes has two sites in 5'UTR. Table 2 shows ig-miRNA sites in CDS with ratio ΔG/ΔGm 80-
99%. Many of mRNAs have some miRNA sites. MiR-4472 has binding sites in CDS of 7 genes 
(AATK, HDAC4, LRP1, MAP2K4, NOTCH1, PTPRJ, SLIT3), where LRP1 gene has three sites and 
NOTCH1 gene has two sites. MiR-4456, miR-4455, miR-4711-3p have bindings sites in CDS six, 
five, four mRNAs according. These miRNAs are important as they have binding sites with many 
mRNAs of studied genes. Table 3 shows ig-miRNA sites in 3'UTR with ratio ΔG/ΔGm 81-84%. 
Characteristics of site location same as in 5'UTR and CDS. BRE, IGF1R and MRE11A genes are 
targets for miR-4456; BBC3 and NOTCH1 genes are targets for miR-1587. These data correspond 
to reliability p < 0.0004. There are miRNAs, their mRNA-targets and position of each binding sites. 
Majority of these miRNAs were revealed recently (with miRNA index number 1000 and more) and 
low-studied. 
 
Interaction of intronic miRNAs with mRNAs genes coding in-miRNA 
In-miRNAs are coded in introns of pre-mRNA, introns of 5'UTR and introns of 3'UTR. 
Binding sites of 686 in-miRNAs with 51 mRNAs were studied (Tables S. 6, 7). 44 mRNAs were 
found to be potential targets according to our threshold significance  (p < 0.0005). Only 128 out of 
the 686 in-miRNAs are involved in the interactions. Seven mRNAs (ABCF1, ATF2, EPHB2, 
HNF4A, MRE11A, SDCCAG8, TNFAIP6 genes) have no binding sites to in-miRNAs. Only miR-
1268b has two binding sites to ВВС3 mRNA. 
 The number of connection with miRNA are significantly different for studied mRNAs. 12 
mRNAs have sites only with one miRNA (Table S. 6).  mRNAs with seven and more binding sites 
are depicted in Table S. 7. The average number of all in-miRNA sites is 2.9. mRNAs of AATK, AKT, 
HDAC4, IGF2 and LRP1 genes have 10, 11, 13, 7 and 14 binding sites, respectively. Some mRNAs 
have more than one binding site with a given in-miRNAs. For example, miR-1268b and miR-4296 
have two binding sites with HDAC4 mRNA. miR-1273f and miR-574-5p have two and five binding 
sites with IGF2 mRNA. 
Density of in-miRNA binding sites in 44 mRNAs are represented in Table S. 10. The miRNA 
site density ranges from 0.17 s/l for AXTXR1 mRNA to 2.74 s/l for BBC3 mRNA. 
5'UTR, CDS and 3'UTR of mRNA of studied genes have different binding ability to miRNA. 
in-miRNAs shares are 16.1%, 46.4% and 37.5% sites in 5'UTR, CDS, 3'UTR of 44 mRNA, 
respectively (Figure 1, B). However, the average binding sites densities of 5'UTR, CDS and 3'UTR 
computed over all mRNAs are 1.82 s/l, 0.63 s/l and 0.72 s/l, respectively (Figure 1, B). Average 
density of binding sites for 5'UTR is 2.9 times more than it is in CDS and 2.6 times more than it is 
in 3'UTR.  These results indicate that miRNAs can bind to 5'UTR, CDS and 3'UTR. 
 In-miRNA sites with the best characteristics are represented in Table 4, there are results with 
the ratio ΔG/ΔGm 80% (p < 0.0004) and more (with equalizing coefficient). Location of miRNA site 
depend on mRNA gene. For example, IGF1R,  LRP1 and IGF2 genes are targets for miR-1273f and 
its site locates in 3'UTR, CDS and 5'UTR corresponding. Characteristics of 81 in-miRNA sites for 
33 mRNAs of target genes encoding other intronic miRNAs in Table S. 3. There are characteristics 
of miRNA binding sites and their origin (gene, where encodes pre-miRNA). These in-miRNAs have 
different origin their pre-miRNAs. Among all in-miRNA, four pre-miRNA encode in introns of 
3'UTR and 20 pre-miRNAs in introns of 5'UTR. LRP1 gene has six miRNA sites in different 
domains of its mRNA: CDS (miR-1273f, miR-4295, miR-4296, miR-500b), 5'UTR (miR-4274) and 
3'UTR (miR-4297). HUWE1 gene has sites (miR-4297, miR-548an, miR-598) only in CDS and 
LFNG gene  has sites (miR-1224-3p, miR-500b) only in 3'UTR. Some mRNAs can be target to in-
miRNAs, that encode in different pre-mRNA genes. For example, IGF1R gene is target for miR-
1268B (CCDC40), miR-1273F (SCP2), miR-3173 (DICER1), miR-361 (CHM), miR-4292 
(C9orf86), miR-4297 (EBF3), where gene origin corresponding pre-miRNA is shown in brackets. 
These data show a linkage between different genes encode intronic miRNAs, where each mRNA is 
target for some miRNAs and encodes other miRNAs. By this means, such genes can affect with 
each other via in-miRNAs.  
 
Interaction of exonic miRNAs with mRNA genes coding in-miRNA 
49 ex-miRNAs are coded in exons of pre-mRNAs, 5'UTRs and 3'UTRs. Binding sites of ex-
miRNAs with 51 mRNAs were studied (Table S. 8). Only 15 out of 49 ex-miRNAs interact with no 
more than 17 target mRNAs. Shares of binding sites for ex-miRNAs are 14.3%, 57.1% and 28.6% 
sites in 5'UTR, CDS, 3'UTR of 17 mRNA, respectively (Figure 1, A). The number of binding sites 
of ex-miRNAs with mRNAs of target genes are different. For example, EPHB2 mRNA has three 
sites one in 5'UTR and two in CDS), and DMD and FOXP1 mRNAs have two sites. There are no 
cases, where mRNA have two and more binding sites. 
5'UTR, CDS and 3'UTR of these genes mRNAs have different binding ability to ex-miRNA. 
The average binding sites density of miRNA in 5'UTR, CDS and 3'UTR equals 0.64 s/l, 0.29 s/l and 
0.18 s/l, respectively (Figure 1, B). Average binding sites density for 5'UTR is 2.2 times more than 
it is in CDS and 3.6 times more than it is in 3'UTR. The sites density ranges from 0.06 s/l for ВIRC6 
mRNA to 0.76 s/l for BIRC7 mRNA with an average value 0.29 s/l (Table S. 11). in-miRNA sites 
with the best characteristics are represented in table 5, there are results with the ratio ΔG/ΔGm 80%  
(p<0.0004) and more (with coefficient equalizing). Despite the small number of target genes, these 
data have proved that ex-miRNA can bind to 5'UTR, CDS and 3'UTR.  
 
HDAC4 mRNA has three types of miRNA binding sites. 
 As is known, it exist three types of binding sites: 5'-dominant canonical, 5'-dominant seed 
only and 3'-compensatory (Betel et al., 2010). Canonical site has good (or perfect) complementarity 
at both the 5'- and 3'-ends of the miRNA with a specific bulge in the middle. Dominant seed site has 
perfect seed 5'-complementarity to the miRNA but poor 3'-complementarity. Compensatory site has 
a mismatch (wobble) in the 5'-seed region but compensate through excellent complementarity at the 
3'-end. 
 5'-dominant canonical and 3'-compensatory types of binding sites were found in our data. 
There is not 5'-dominant seed only type of binding sites, because such sites have low energy of 
binding site and are not reliable according to our criteria. In addition, complementary type of 
miRNA binding sites was found after analyze of our results. It has perfect complementarity 
beginning with second nucleotide and completing the last but one nucleotide of mRNA in binding 
site. There is not a bugle in the middle like in canonical site (Table 6). Such binding sites have high 
energy of binding site and are reliable according to our criteria. 
HDAC4 mRNA has three types of miRNA binding sites. An example, 5'-dominant canonical 
sites are in-miR-4296 and ig-miR-3195; 3'-compensatory sites are ig-miR-4311 and in-miR-1914*; 
complementary sites are ig-miR-4478 and in-miR-1289 (Table 6). The primary contribution to 
energy can include all parts of miRNA site but not only 5'seed. 
HDAC4 mRNA is a target for several intergenic and intronic miRNAs. In both cases, sites 
may be found in any region. HDAC4 mRNA has seven, nine and seven sites for intergenic miRNAs 
in 5'UTR, CDS and 3'UTR, respectively (Table S. 4). It has eight, two and five sites for intronic 
miRNAs in 5'UTR, CDS and 3'UTR, respectively (Table S. 7). A specific attention is paid to two 
miRNAs (miR-1268b and miR-4296) that have two binding sites with HDAC4 mRNA. In both 
cases, two homologous sites can be found in 5'UTR. 
Two sites of miR-4787-5p are located in 5'UTR of HDAC4 mRNA and they are highly 
homological. miR-1587 and miR-4507 are placed in the same site HDAC4 mRNA (Table S. 5). 
These examples indicate a highly specific interaction between miRNAs and mRNAs. Found sites 
have high hybridization energy due to significant amount of complementary nucleotides. 
 
Discussion 
According to (Friedman et al., 2009), expression may be regulated by miRNAs for more than 
a half of human genes. The number of known human miRNAs constantly increases, as well as the 
number of potential target genes for them. The establishment of target genes depends on efficiency 
of their prediction by computer methods. Indeed, experimental verification of predicted target genes 
depends on accuracy of prediction of miRNA sites and their characteristics considered in 
corresponding programs. Besides, the essential role of prediction of binding sites and their 
validation have limitation depending on quality of prediction (Grimson et al., 2007). 
In earlier publications, several tens or hundreds miRNAs were investigated by researchers. In 
our search work, interaction sites of 1519 miRNAs with 51 mRNA-targets are presented. Total 
number of miRNA sites found in all target genes is 439. Some miRNAs have several binding sites 
with the same mRNA. Average number of binding sites is 6 miRNAs on mRNA. MiRNA sites with 
high ratio ΔG/ΔGm value were selected with p < 0.0005. In-miRNAs and ig-miRNAs have similar 
properties. miRNAs with length 22 n. have distinct prevalence concerning others which have bigger 
or smaller length. A great number of in-miRNAs and ig-miRNAs have a high GC-content (50-
55%). Most genes under study appear to have binding sites with miRNA. Therefore, it is possible 
that the expression of a significant part of human genes is under a regulation control by miRNAs. 
Ig-miR-4456, ig-miR-4455, ig-miR-4492, ig-miR-302f, ig-miR-3195 have bindings sites in 
CDS eight, six, five and five mRNAs according. In-miR-1268b, in-miR-4753-3p, in-miR-574-5p 
have bindings sites in CDS six, four and four mRNAs according. The expression of such miRNAs 
can repress translation of many genes, that participate in development cancer. 
The shares of all binding sites 15.8%, 53.1% and 31.1% in 5'UTR, CDS, 3'UTR of 51 mRNA 
respectively were found (Figure 1, A). Shares of in-miRNA and ig-miRNA that have binding sites 
 in 5'UTR, CDS and 3'UTR are similar. However the average number of in-miRNA sites towards 
single mRNA is 19% more than it is to ig-miRNA.  
 Thus, the density of binding sites in 5'UTR is 2.6 times more than it is in CDS and 2.8 times 
more than it is in 3'UTR. Such data indicate that ig-miRNAs can interact with 5'UTR and CDS, and 
not only with 3'UTR. Some miRNAs have a high site density in 5'UTR. 
A significant part of studied miRNAs interact with mRNA of only one gene. Action on such 
miRNAs would allow for a selective modification of associated target genes expression. MRNA of 
some genes is targets for ig-miRNAs and in-miRNAs. 
 
Conclusions 
Computational prediction of miRNA binding sites is important stage in investigation 
biological function miRNA. These data promote understanding features of gene regulation on post-
transcription level via microRNAs. The linkage between different genes encode in-miRNAs and are 
targets for in-miRNAs were revealed. These genes participate in different cellular processes and 
revealing linkages between such genes participating in gastrointestinal cancer. 
It has been found that the percentage of ig-miRNA, ex-miRNA, in-miRNA sites are 
approximately identical in 5'UTR, CDS, 3'UTR. Approximately 2/3 of these sites bind to 5'UTR or 
CDS regions. This suggests that sites involved in a translation regulation by miRNAs are located in 
5'UTR and CDS regions, and not only in 3'UTR.  
 On these data, around 45% of miRNAs are intronic and their synthesis directly depends on 
transcription of corresponding host genes. In-miRNAs have no strong binding to mRNAs of 51 
studied genes. Therefore in-miRNA do not inhibit the expression of host genes.  
Three types of schemes of interaction between mRNA and miRNA were revealed. There are 
5'-dominant canonical sites, 3'-compensatory sites and complementary sites. The primary 
contribution to energy can include all parts of miRNA site but not only 5'seed. Hence all parts of 
miRNA sites can bring contribution to the total energy of site
 (ΔG/ΔGm). 
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Note: These binding sites have ratio ΔG/ΔGm equal 70– 99%. 
A – Shares of miRNAs binding sites with different parts of 51 mRNAs. 
B – Average number of miRNA binding sites with different parts of 51 mRNAs. 
 
Fig. 1. Characteristics of miRNA binding sites with different parts of all mRNAs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table 1. Characteristics of sites binding ig-miRNA with 5'UTR mRNA 
 
Gene miRNA Posi-
tion 
 Gene miRNA Posi-
tion 
 Gene miRNA Posi-
tion 
AATK miR-4417 45  HDAC4 miR-1268 80  NR2F2 miR-4253 537 
ATF2 miR-4319 63  HNF4A miR-302f 71  miR-4787-5p 1152 
BRE miR-4455 39  miR-1279 1  PRKG1 miR-1268 142 
DCC miR-568 524  miR-4307 76  PTK2 miR-3676 22 
DTL miR-4309 44  HUWE1 miR-4266 134  PTPRJ miR-3195 288 
EGFL7 miR-4289 4  LRP1 miR-4307 188  SDCCAG8 miR-4309 20 
miR-1204 301  miR-4472 99  SLIT3 miR-4507 61 
EPCAM miR-4456 112  MCM7 miR-4289 453  miR-4466 253 
miR-4492 137  MTUS1 miR-3195 141  miR-4481 314 
miR-4508 140  NR2F2 miR-4443 556  SPATA13 miR-4279 12 
HDAC4 miR-3195 266  miR-1538 289     
Note: These binding sites have ratio ΔG/ΔGm equal 80-92% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table 2. Characteristics of sites binding ig-miRNA with CDS mRNA 
 
Gene miRNA Posi
-tion 
 Gene miRNA Posi-
tion 
 Gene miRNA Posi-
tion 
AATK miR-3195 1352  EPHB2 miR-4316 1293  LRP1 miR-4455 12015 
miR-4472 1684  miR-4466 1334  miR-4266 5093 
miR-4711-3p 2715  ERBB4 miR-4443 1940  miR-132 4503 
miR-4492 3345  EVL miR-4711-3p 802  miR-4472 13015 
miR-1538 1339  miR-3180 816  miR-4456 2930 
miR-4265 3143  FOXP1 miR-4736 1146  miR-1261 7704 
AKT2 miR-4492 1370  miR-4266 1126  miR-4253 10550 
ANTXR1 miR-4711-3p 1772  miR-320d 2225  MAP2K4 miR-4472 120 
miR-3141 2010  miR-4264 2506  MAP7D2 miR-4417 1395 
BBC3 miR-4483 744  miR-1279 2111  MCM7 miR-4483 1975 
miR-4710 796  miR-4327 2392  MRE11A miR-520e 693 
miR-3665 410  GIPR miR-659 1441  miR-302f 852 
miR-4466 319  HDAC4 miR-4483 2802  NOTCH1 miR-4472 4308 
miR-4278 884  miR-4481 1868  miR-4472 7474 
BCAS1 miR-4307 871  miR-302e 2082  miR-4455 6381 
BID miR-596 364  miR-4472 2159  miR-4455 6997 
BIRC7 miR-4456 372  miR-1205 976  miR-516a-3p 6964 
BRE miR-3201 878  miR-4746-3p 982  miR-516b* 6964 
CCAR1 miR-548ak 3272  HNF4A miR-1204 278  miR-4736 75 
miR-4463 841  miR-4456 465  miR-4283 1245 
CDH13 miR-4455 2032  HUWE1 miR-320c 3048  PRKG1 miR-599 2933 
DCC miR-4711-3p 3297  miR-4307 3373  PTPRJ miR-4472 2750 
miR-1207-3p 3190  miR-4264 6886  SLIT3 miR-302e 3310 
miR-4318 1684  miR-1279 10486  miR-4472 3745 
miR-4325 2917  miR-320d 3050  miR-302f 3310 
DMD miR-4282 2958  miR-4443 4959  miR-4513 499 
miR-4493 5132  miR-4792 10624  miR-4508 1201 
miR-4520a-5p 1878  IGF1R miR-4456 462  miR-4481 4872 
miR-4520b-5p 1878  miR-4282 528  miR-4492 1201 
miR-4650-5p 5135  miR-1268 1535  SPATA13 miR-1261 1854 
DNMT3A miR-302f 3075  LFNG miR-4264 1154  miR-4266 2070 
miR-3676 1221  miR-1274b 175  miR-4456 2864 
miR-665 1570  miR-3195 178  TNKS miR-4455 3891 
miR-4456 2223  LRP1 miR-4472 11274  miR-4531 647 
EIF4H miR-645 705  miR-4472 2781  miR-4465 1769 
EPHB2 miR-4253 1087  miR-4283 12932     
Note: These binding sites have ratio ΔG/ΔGm equal 80-99% 
 Table 3. Characteristics of sites binding ig-miRNA with 3'UTR mRNA 
 
Gene miRNA Posi-
tion 
 Gene miRNA Posi-
tion 
 Gene miRNA Posi-
tion 
AATK miR-4472 4514  EPHB2 miR-4455 4792  IGF1R miR-4455 8927 
AKT2 miR-4316 2472  ERBB4 miR-4279 10500  miR-769-3p 7824 
miR-4418 3951  miR-568 11012  miR-4455 10709 
miR-4264 2336  miR-3123 4973  LFNG miR-466 1269 
BBC3 miR-4507 1000  miR-302f 5163  miR-4318 1899 
miR-4505 1000  miR-513a-5p 4123  LRP1 miR-4328 14372 
miR-4497 965  FBXW7 miR-3674 3468  MAP2K4 miR-1827 3050 
miR-3676 1616  FOXP1 miR-466 5945  MCM7 miR-4466 2782 
miR-1587 1000  miR-4266 3217  MRE11A miR-4456 3832 
miR-4279 1636  HDAC4 miR-4478 8388  MTUS1 miR-513a-5p 4652 
BID miR-543 2428  miR-4529-5p 6541  miR-4443 6051 
BRE miR-4456 1575  miR-4482 7344  miR-3168 4674 
CDH13 miR-297 3603  miR-4710 8162  miR-513b 4652 
DCC miR-302f 6493  miR-4311 7024  NOTCH1 miR-1587 8133 
EGFL7 miR-3130-5p 1454  miR-4328 4662  miR-1275 9070 
EIF4H miR-4309 1364  HNF4A miR-3934 1350  SPATA13 miR-876-3p 6126 
miR-197 1627  IGF1R miR-4456 7101     
Note: These binding sites have ratio ΔG/ΔGm equal 80-94% 
 
 
 Table 4. Characteristics of sites binding in-miRNA with 5'UTR, CDS, 3'UTR mRNA 
 
Gene miRNA Posi-
tion 
 Gene miRNA Posi-
tion 
 Gene miRNA Posi-
tion 
5'UTR  DNMT3A miR-593 674  BBC3 miR-3156-3p 1667 
BIRC7 miR-4292 60  ERBB4 miR-3182 3863  CDH13 miR-574-5p 3603 
EPCAM miR-4753-3p 7  miR-4797-3p 3376  EBF3 miR-500b 2252 
miR-4317 45  EVL miR-1322 522  miR-1976 2260 
GIPR miR-26a-1* 25  miR-4281 1001  EGFL7 miR-3130-5p 1454 
HDAC4 miR-1914* 540  GIPR let-7g 140  EIF4H miR-4263 1611 
miR-1268b 78  miR-1238 182  ERBB4 miR-483-3p 10500 
miR-4296 53  LRP1 miR-1273f 3301  miR-877* 10504 
miR-4296 159  miR-4295 6360  HDAC4 miR-1289 6515 
IGF2 miR-1273f 81  miR-500b 1824  miR-4326 4606 
LRP1 miR-4274 428  NOTCH1 miR-3196 688  IGF1R miR-4292 6166 
PRKG1 miR-1268b 140  miR-1271 1240  miR-3173-5p 5679 
PTPRJ miR-1238 208  PTPRJ miR-342-5p 459  miR-361-3p 7089 
CDS  SLIT2 miR-4446-3p 4223  miR-1273f 7624 
AATK miR-4651 4029  SLIT3 miR-500b 426  IGF2 miR-1273f 1902 
ABCA6 miR-3941 3053  SPATA13 miR-652 482  miR-4263 3055 
BBC3 miR-4655-3p 598  3'UTR  miR-3972 4533 
BID miR-4285 432  AATK miR-648 4498  miR-4296 4307 
BIRC7 miR-4257 745  AKT2 miR-3196 1865  LFNG miR-1224-3p 2007 
BRE miR-4259 315  miR-4281 2711     
DMD miR-4753-3p 11190  ANTXR1 miR-32* 5217     
Note: These binding sites have ratio ΔG/ΔGm equal 80-91% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 5. Characteristics of sites binding ex-miRNA with 5'UTR, CDS, 3'UTR mRNA 
 
Gene miRNA Position  Gene miRNA Position  Gene miRNA Position 
CDS  DMD miR-1306 2819  3'UTR 
BIRC6 miR-4315 11064  GIPR miR-671-5p 1236  DNMT3A miR-4775 3420 
BIRC7 miR-1825 373  HUWE1 miR-3652 6967  MTUS1 miR-1306 5360 
DMD miR-4315 6086         
Note: These binding sites have ratio ΔG/ΔGm equal 81-84% 
 
 Table 6. Schematic representation of  types of bindings sites miRNAs with mRNA HDAC4 
 
5'UTR,53   ΔG=-33,5  ΔG/ΔGm=84    5'-d/c  5'UTR,266   ΔG=-38,8  ΔG/ΔGm=84   5'-d/c 
mRNA         5' C     C         C 3'  
                 GAGCC GAGCCCGCG    
                 CUCGG CUCGGGUGU      
in-miR-4296  3' A     A         A 5'  
 mRNA          5' C     C          C 3'  
                  AGCCC GGCCCGGCGC   
                  UUGGG CCGGGCCGCG                           
ig-miR-3195   3'       C          C 5' 
   
3'UTR,7024  ΔG=-28,8  ΔG/ΔGm=80   3'-compn.  5'UTR,540   ΔG=-46,8  ΔG/ΔGm=81   3'-compn. 
mRNA          5' A              C    3'   
                  CACACUCGGCUCUU                        
                  GUGUGAGUCGAGAG                                        
ig-miR-4311   3'                AAAG 5'  
 mRNA         5'G                  G G  C 3'  
      UCUCCCGGUGCGGGGCCC C CC      
GGAGGGUCACGCCCUGGG G GG     
in-miR-1914* 3'                     A    5' 
   
3'UTR,8388  ΔG=-34,6  ΔG/ΔGm=87   compl.   3'UTR,6515  ΔG=-36,7  ΔG/ΔGm=80   compl.   
mRNA          5' G                A 3'  
                  UUCUUAGCUCGGCCUC                         
                  AGGAGUCGAGUCGGAG                                        
ig-miR-4478   3' G                  5'  
 mRNA          5' U                    A  3' 
     GAGUGCAGAUUCUUGGAUUC       
UUUACGUCUAAGGACCUGAG      
in-miR-1289   3' U                    GU 5' 
Note. Site localization of 5'-binding sites of nucleotide interaction miRNAs with mRNAs are shown. Interaction energy 
(ΔG) is measured in kcal/mol. The ΔG/ΔGm value is measured in percents. Types of bindings sites: 5'-d/c – 5'-dominant 
canonical, 3'-comp. – 3'-compensatory,  compl. – complementary site. 
 
